{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T14:05:56Z","timestamp":1790690756615,"version":"4.1.0"},"reference-count":20,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,4,24]],"date-time":"2026-04-24T00:00:00Z","timestamp":1776988800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Blood Neoplasia"],"published-print":{"date-parts":[[2026,8]]},"DOI":"10.1016\/j.bneo.2026.100240","type":"journal-article","created":{"date-parts":[[2026,4,25]],"date-time":"2026-04-25T10:19:53Z","timestamp":1777112393000},"page":"100240","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Autologous transplant for patients with chemotherapy-sensitive late relapse of diffuse large B-cell lymphoma"],"prefix":"10.1016","volume":"3","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3165-1899","authenticated-orcid":false,"given":"Lorenzo","family":"Iovino","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ningxin","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7394-5185","authenticated-orcid":false,"given":"Mohamed A.","family":"Kharfan-Dabaja","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9665-7415","authenticated-orcid":false,"given":"Alex F.","family":"Herrera","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Craig S.","family":"Sauter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5372-510X","authenticated-orcid":false,"given":"Mehdi","family":"Hamadani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2719-0580","authenticated-orcid":false,"given":"Peter A.","family":"Riedell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3023-6834","authenticated-orcid":false,"given":"Ajay K.","family":"Gopal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3277-1910","authenticated-orcid":false,"given":"Leona","family":"Holmberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2292-4816","authenticated-orcid":false,"given":"Qian Vicky","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9893-4949","authenticated-orcid":false,"given":"Sonali M.","family":"Smith","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3365-6562","authenticated-orcid":false,"given":"Mazyar","family":"Shadman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"7","key":"10.1016\/j.bneo.2026.100240_bib1","doi-asserted-by":"crossref","first-page":"640","DOI":"10.1056\/NEJMoa2116133","article-title":"Axicabtagene ciloleucel as second-line therapy for large B-cell lymphoma","volume":"386","author":"Locke","year":"2022","journal-title":"N Engl J Med"},{"issue":"24","key":"10.1016\/j.bneo.2026.100240_bib2","doi-asserted-by":"crossref","first-page":"2671","DOI":"10.1200\/JCO-25-00399","article-title":"Lisocabtagene maraleucel versus standard of care for second-line relapsed\/refractory large B-cell lymphoma: 3-year follow-up from the randomized, phase III TRANSFORM study","volume":"43","author":"Kamdar","year":"2025","journal-title":"J Clin Oncol"},{"issue":"15","key":"10.1016\/j.bneo.2026.100240_bib3","doi-asserted-by":"crossref","first-page":"3694","DOI":"10.1182\/bloodadvances.2024015262","article-title":"Lisocabtagene maraleucel for R\/R LBCL in patients not intended for HSCT: final results of the phase 2 PILOT study","volume":"9","author":"Sehgal","year":"2025","journal-title":"Blood Adv"},{"issue":"27","key":"10.1016\/j.bneo.2026.100240_bib4","doi-asserted-by":"crossref","first-page":"4184","DOI":"10.1200\/JCO.2010.28.1618","article-title":"Salvage regimens with autologous transplantation for relapsed large B-cell lymphoma in the rituximab era","volume":"28","author":"Gisselbrecht","year":"2010","journal-title":"J Clin Oncol"},{"issue":"27","key":"10.1016\/j.bneo.2026.100240_bib5","doi-asserted-by":"crossref","first-page":"3059","DOI":"10.1200\/JCO.2013.54.8800","article-title":"Recommendations for initial evaluation, staging, and response assessment of Hodgkin and non-Hodgkin lymphoma: the Lugano classification","volume":"32","author":"Cheson","year":"2014","journal-title":"J Clin Oncol"},{"issue":"1","key":"10.1016\/j.bneo.2026.100240_bib6","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1038\/s41408-024-01084-w","article-title":"Autologous transplant vs. CAR-T therapy in patients with DLBCL treated while in complete remission","volume":"14","author":"Shadman","year":"2024","journal-title":"Blood Cancer J"},{"issue":"9","key":"10.1016\/j.bneo.2026.100240_bib7","doi-asserted-by":"crossref","first-page":"1330","DOI":"10.1182\/blood.2021013289","article-title":"Autologous transplant vs chimeric antigen receptor T-cell therapy for relapsed DLBCL in partial remission","volume":"139","author":"Shadman","year":"2022","journal-title":"Blood"},{"issue":"3","key":"10.1016\/j.bneo.2026.100240_bib8","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1200\/JCO.1995.13.3.588","article-title":"BEAM chemotherapy and autologous bone marrow transplantation for patients with relapsed or refractory non-Hodgkin's lymphoma","volume":"13","author":"Mills","year":"1995","journal-title":"J Clin Oncol"},{"issue":"suppl 1","key":"10.1016\/j.bneo.2026.100240_bib9","doi-asserted-by":"crossref","first-page":"2744","DOI":"10.1182\/blood-2025-2744","article-title":"CAR T-cell therapy versus autologous HSCT in patients with large B-cell lymphoma in complete remission: an analysis from the EBMT lymphoma working party","volume":"146","author":"Dulery","year":"2025","journal-title":"Blood"},{"issue":"16 suppl","key":"10.1016\/j.bneo.2026.100240_bib10","doi-asserted-by":"crossref","first-page":"7032","DOI":"10.1200\/JCO.2024.42.16_suppl.7032","article-title":"Epcoritamab + R-DHAX\/C in transplant-eligible patients (pts) with high-risk relapsed or refractory (R\/R) diffuse large B-cell lymphoma (DLBCL)","volume":"42","author":"Karimi","year":"2024","journal-title":"J Clin Oncol"},{"issue":"11","key":"10.1016\/j.bneo.2026.100240_bib11","doi-asserted-by":"crossref","first-page":"1729","DOI":"10.1016\/j.bbmt.2014.06.036","article-title":"Early failure of frontline rituximab-containing chemo-immunotherapy in diffuse large B cell lymphoma does not predict futility of autologous hematopoietic cell transplantation","volume":"20","author":"Hamadani","year":"2014","journal-title":"Biol Blood Marrow Transplant"},{"issue":"7","key":"10.1016\/j.bneo.2026.100240_bib12","doi-asserted-by":"crossref","first-page":"2186","DOI":"10.3324\/haematol.2023.284704","article-title":"Autologous stem cell transplant in fit patients with refractory or early relapsed diffuse large B-cell lymphoma that responded to salvage chemotherapy","volume":"109","author":"Tun","year":"2024","journal-title":"Haematologica"},{"issue":"8","key":"10.1016\/j.bneo.2026.100240_bib13","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1016\/j.jtct.2023.05.011","article-title":"Survival outcomes for patients with relapsed\/ refractory aggressive B cell lymphomas following receipt of high-dose chemotherapy\/autologous stem transplantation and\/or chimeric antigen receptor-modified T cells","volume":"29","author":"Landsburg","year":"2023","journal-title":"Transplant Cell Ther"},{"issue":"11","key":"10.1016\/j.bneo.2026.100240_bib14","doi-asserted-by":"crossref","first-page":"2733","DOI":"10.1007\/s00277-021-04650-5","article-title":"The role of autologous stem cell transplantation (ASCT) in aggressive B-cell lymphomas: real-world data from a retrospective single-center analysis","volume":"100","author":"Wullenkord","year":"2021","journal-title":"Ann Hematol"},{"issue":"1","key":"10.1016\/j.bneo.2026.100240_bib15","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1038\/s41408-024-01085-9","article-title":"Hematopoietic stem cell transplantation for DLBCL: a report from the European Society for Blood and Marrow Transplantation on more than 40,000 patients over 32 years","volume":"14","author":"Berning","year":"2024","journal-title":"Blood Cancer J"},{"issue":"10","key":"10.1016\/j.bneo.2026.100240_bib16","doi-asserted-by":"crossref","first-page":"1416","DOI":"10.1182\/blood.2020007939","article-title":"Is autologous transplant in relapsed DLBCL patients achieving only a PET+ PR appropriate in the CAR T-cell era?","volume":"137","author":"Shah","year":"2021","journal-title":"Blood"},{"issue":"11","key":"10.1016\/j.bneo.2026.100240_bib17","doi-asserted-by":"crossref","first-page":"2586","DOI":"10.1182\/bloodadvances.2022009622","article-title":"ASCT vs CART for patients with relapsed LBCL in PR: role of TMTV","volume":"7","author":"Strati","year":"2023","journal-title":"Blood Adv"},{"issue":"10","key":"10.1016\/j.bneo.2026.100240_bib18","doi-asserted-by":"crossref","first-page":"1001.e1","DOI":"10.1016\/j.jtct.2024.07.008","article-title":"Autologous stem cell transplant in fit patients with late relapsed diffuse large B-cell lymphoma that responded to salvage chemotherapy","volume":"30","author":"Tun","year":"2024","journal-title":"Transplant Cell Ther"},{"issue":"1","key":"10.1016\/j.bneo.2026.100240_bib19","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1200\/JCO.2016.68.2740","article-title":"Relapsed or refractory double-expressor and double-hit lymphomas have inferior progression-free survival after autologous stem-cell transplantation","volume":"35","author":"Herrera","year":"2017","journal-title":"J Clin Oncol"},{"issue":"13","key":"10.1016\/j.bneo.2026.100240_bib20","doi-asserted-by":"crossref","first-page":"3281","DOI":"10.1182\/bloodadvances.2024015415","article-title":"Autologous stem cell transplantation for relapsed\/refractory large B-cell lymphoma: a multicenter GETH-TC\/GELTAMO study","volume":"9","author":"Bento","year":"2025","journal-title":"Blood Adv"}],"container-title":["Blood Neoplasia"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2950328026000518?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2950328026000518?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T13:16:04Z","timestamp":1790687764000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2950328026000518"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8]]},"references-count":20,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2026,8]]}},"alternative-id":["S2950328026000518"],"URL":"https:\/\/doi.org\/10.1016\/j.bneo.2026.100240","relation":{},"ISSN":["2950-3280"],"issn-type":[{"value":"2950-3280","type":"print"}],"subject":[],"published":{"date-parts":[[2026,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Autologous transplant for patients with chemotherapy-sensitive late relapse of diffuse large B-cell lymphoma","name":"articletitle","label":"Article Title"},{"value":"Blood Neoplasia","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bneo.2026.100240","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 American Society of Hematology. Published by Elsevier Inc. Licensed under Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International (CC BY-NC-ND 4.0), permitting only noncommercial, nonderivative use with attribution. All other rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"100240"}}